Business
Announcement on Completion of Filing with China Securities Regulatory Commission for Application for Full Circulation of Domestic Unlisted Shares of Holding Subsidiary
Announcement on Completion of Filing with China Securities Regulatory Commission for Application for Full Circulation of Domestic Unlisted Shares of Holding Subsidiary

About this update from Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class A
Announcement on Completion of Filing with China Securities Regulatory Commission for Application for Full Circulation of Domestic Unlisted Shares of Holding Subsidiary The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment
View stock analysis, news, and events for Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class A
More from Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class A
Fosun Pharma Announces 2026 Interim Results
August 25, 2026
"Shanghai Fosun Pharmaceutical (Group) Co., Ltd."Announcement on Progress in Providing Guarantee for Controlled Subsidiary
August 7, 2026
All Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class A news →